Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting innate immune pathways for cancer immunotherapy
Longyue L. Cao, Jonathan C. Kagan
Immunity (2023) Vol. 56, Iss. 10, pp. 2206-2217
Open Access | Times Cited: 67

Showing 26-50 of 67 citing articles:

Advances of ultrasound in tumor immunotherapy
Jing Lin, Yu‐Wei Wu, Guangde Liu, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112233-112233
Closed Access | Times Cited: 4
Self-modifying NanoEnhancers facilitating lysosomal escape for cGAS-STING cascading activation in tumor immunotherapy
Yanni Ge, Yuheng Bao, An Shao, et al.
Nano Today (2024) Vol. 57, pp. 102391-102391
Closed Access | Times Cited: 4
CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer
Wei Li, Feng Guo, Ruijiang Zeng, et al.
Cancer Research (2024) Vol. 84, Iss. 16, pp. 2588-2606
Closed Access | Times Cited: 3
Identification and validation of immune-related gene signature models for predicting prognosis and immunotherapy response in hepatocellular carcinoma
Zhiqiang Liu, Lingge Yang, Chun Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Harnessing Bacterial Membrane Components for Tumor Vaccines: Strategies and Perspectives
Zhenxin Bai, Xuanyu Wang, Tianming Liang, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 3
Lymphocyte homing and recirculation with tumor tertiary lymphoid structure formation: predictions for successful cancer immunotherapy
Weihong Tian, Wangzhi Wei, Gaofeng Qin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Parkin activates innate immunity and promotes anti-tumor immune responses
Michela Perego, Minjeong Yeon, Ekta Agarwal, et al.
Journal of Clinical Investigation (2024)
Open Access | Times Cited: 3
Inhibiting autophagy enhanced mitotic catastrophe-mediated anticancer immune responses by regulating the cGAS-STING pathway
Zhaoshi Bai, Yaling Peng, Xue'er Xia, et al.
Cancer Letters (2024) Vol. 586, pp. 216695-216695
Closed Access | Times Cited: 2
Metabolic rewiring and communication in cancer immunity
Nicole M. Chapman, Hongbo Chi
Cell chemical biology (2024) Vol. 31, Iss. 5, pp. 862-883
Open Access | Times Cited: 2
Targeting Innate Immunity in Glioma Therapy
Andrew G. Gillard, Dong Ho Shin, Lethan A Hampton, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 947-947
Open Access | Times Cited: 2
The first embryo, the origin of cancer and animal phylogeny. IV. The neoplastic basis for the formation of the innate immune system
Jaime Cofré
Frontiers in Ecology and Evolution (2024) Vol. 11
Open Access | Times Cited: 1
MMP11 as a prognostic biomarker correlated with immune infiltrates in pancreatic adenocarcinoma
Zhengxuying Fang, Xiaoyu Xu, Linglong Tao, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 3, pp. 1224-1244
Open Access | Times Cited: 1
Immunotherapy with γδ T-cells: the future is there
Dieter Kabelitz, Zhinan Yin
Immunotherapy (2024) Vol. 16, Iss. 11, pp. 705-708
Closed Access | Times Cited: 1
A New Ferroptosis-Related Long Non-Coding RNA Risk Model Predicts the Prognosis of Patients With Papillary Thyroid Cancer
Jun Yu Zhao, Jin Ming Yao, Xin Zhang, et al.
World Journal of Oncology (2024) Vol. 15, Iss. 4, pp. 648-661
Closed Access | Times Cited: 1
Novel Carbon Quantum Dots Precisely Trigger Ferroptosis in Cancer Cells through Antioxidant Inhibition Synergistic Nanocatalytic Activity
Nianqiang Jin, Zilin Wang, Chengcheng Yin, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 29, pp. 37456-37467
Closed Access | Times Cited: 1
Engineering CaP-Pickering emulsion for enhanced mRNA cancer vaccines via dual DC and NK activations
Sihua Wu, Yan Zhou, Naoki Asakawa, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 837-852
Closed Access | Times Cited: 1
Advances in immunotherapy for mucosal melanoma: harnessing immune checkpoint inhibitors for improved treatment outcomes
Zexing Shan, Fei Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Unlocking Intracellular Protein Delivery by Harnessing Polymersomes Synthesized at Microliter Volumes using Photo‐PISA
Chalaisorn Thanapongpibul, Omar Rifaie‐Graham, Miina Ojansivu, et al.
Advanced Materials (2024)
Open Access | Times Cited: 1
Machine learning reveals CAT gene as a novel potential diagnostic and prognostic biomarker in non-small cell lung cancer
Yi Tian, Wen-Ya Zhao, Yiru Liu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Tumor‐Associated Myeloid Cells Selective Delivery of a Therapeutic Tumor Nano‐Vaccine for Overcoming Immune Barriers for Effective and Long‐Term Cancer Immunotherapy
Chufan Wang, Jinglian Zhao, yufei Duan, et al.
Advanced Healthcare Materials (2024)
Closed Access | Times Cited: 1
Self-delivery nanodrug to manipulate tumor microenvironment for boosting photodynamic cancer immunotherapy
Xianquan Feng, Lingjun Zeng, Lina Wu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117220-117220
Open Access | Times Cited: 1
Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapy
Jesse Garcia Castillo, Sebastían Fernández, Timothy Campbell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
VDX‐111, a novel small molecule, induces necroptosis to inhibit ovarian cancer progression
Christianne Persenaire, Beatrice Babbs, Tomomi M. Yamamoto, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1248-1259
Closed Access
SLC2A3 is a Potential Factor for Head and Neck Squamous Cancer Development through Tumor Microenvironment Alteration
Wei Jiang, Sheng Xu, Ping Li
Current Gene Therapy (2024) Vol. 25, Iss. 2, pp. 157-177
Closed Access
The promise, progress, and challenges of in situ immunization agents in cancer immunotherapy
Matthew J. Giacalone
Progress in molecular biology and translational science (2024), pp. 127-164
Closed Access

Scroll to top